Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Texas Southwestern Medical Center |
---|---|
Information provided by: | University of Texas Southwestern Medical Center |
ClinicalTrials.gov Identifier: | NCT00622180 |
To assess over a 25-week period the efficacy of hand-foot narrow-band ultraviolet B light versus focal 308-nm light treatment in inducing the return of pigment in vitiligo after skin minigraft transplants to the backs of the hands in patients with light brown to black skin. Subject will undergo treatment for 13 weeks.
Condition | Intervention |
---|---|
Vitiligo |
Device: Daavlin Spectra UVB Hand/Foot Box Device: Excilite Focal 308-nm light |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Investigator), Active Control, Single Group Assignment, Safety/Efficacy Study |
Official Title: | The Efficacy of Hand-Foot Narrow-Band UVB Versus Focal 308-nm Treatment in Inducing Repigmentation of Vitiligo After Minigrafting on the Dorsal Hands |
Estimated Enrollment: | 25 |
Study Start Date: | January 2008 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
Right hand treated with narrow-band UVB light and left hand treated with focal 308-nm light
|
Device: Daavlin Spectra UVB Hand/Foot Box
Narrow-band ultraviolet B hand box
|
2: Active Comparator
Right hand treated with focal 308-nm light and left hand treated with narrow-band UVB light
|
Device: Excilite Focal 308-nm light
Excilite Focal 308-nm light
|
Prospective investigator-blinded study involving 25 adult male and female subjects with vitiligo on the backs of both hands. Punch minigrafting will be performed on both hands taking skin from the thighs and/or buttocks. Light treatments will be administered starting at week one after grafting. One hand will receive narrow-band ultraviolet B light and the other will receive focal 308-nm light treatments. Light treatments will be administered 3 times per week for 12 weeks. A long term follow-up visit will be completed at week 25. The investigator will evaluate the subjects at week 4, 7, 13 and 25 in addition to screening and baseline evaluations/procedures.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Texas | |
UT Southwestern Medical Center at Dallas - Dermatology Clinical Trials | |
Dallas, Texas, United States, 75390-8802 |
Principal Investigator: | Amit Pandya, M.D. | UT Southwestern Medical Center at Dallas - Department of Dermatology |
Responsible Party: | UT Southwestern Medical Center at Dallas ( Amit Pandya, M.D. - Professor of Dermatology ) |
Study ID Numbers: | IRB file number 122007-003, 122007-003 |
Study First Received: | January 23, 2008 |
Last Updated: | January 21, 2009 |
ClinicalTrials.gov Identifier: | NCT00622180 History of Changes |
Health Authority: | United States: Institutional Review Board |
Vitiligo Light treatment for vitiligo Excilite |
Hypopigmentation Skin Diseases Pigmentation Disorders Hypomelanotic Disorder Vitiligo |
Hypopigmentation Skin Diseases Pigmentation Disorders Vitiligo |